Patents by Inventor Johannes-Peter Stasch

Johannes-Peter Stasch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-Tetrazolyl Indazoles, 3-Tetrazolyl Pyrazolopyridines, and use Thereof
    Publication number: 20100113507
    Abstract: The present application relates to novel 3-tetrazolylindazole and 3-tetrazolylpyrazolo[3,4-b]-pyridine derivatives, processes for their preparation, their use alone or in combination for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prevention of cardiovascular disorders.
    Type: Application
    Filed: April 30, 2007
    Publication date: May 6, 2010
    Applicant: BAYER HEALTHCARE AG
    Inventors: Chantal Fürstner, Hartmut Schirok, Nils Griebenow, Joachim Mittendorf, Johannes-Peter Stasch, Frank Wunder
  • Substituted aminodicarboxylic acid derivatives having pharmaceutical properties
    Patent number: 7705043
    Abstract: The invention relates to compounds of formula (I) and their salts and stereoisomers in which the variables are as defined in the description and claims, for producing medicaments used in the treatment of cardiovascular and other diseases. Such compounds, processes for preparing them, compositions containing them, and methods of using them are claimed.
    Type: Grant
    Filed: October 10, 2006
    Date of Patent: April 27, 2010
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Cristina Alonso-Alija, Michael Harter, Michael Hahn, Josef Pernerstorfer, Stefan Weigand, Johannes-Peter Stasch, Frank Wunder
  • SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF
    Publication number: 20100099681
    Abstract: The present application relates to novel substituted 5-aminopyrazoles, methods of production thereof, use thereof alone or in combinations for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases.
    Type: Application
    Filed: August 13, 2009
    Publication date: April 22, 2010
    Applicant: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
    Inventors: Lars Bärfacker, Raimund Kast, Nils Griebenow, Heinrich Meier, Peter Kolkhof, Barbara Albrecht-Küpper, Adam Nitsche, Nicole Teusch, Johannes-Peter Stasch, Dirk Schneider
  • Halogen-substituted aminodicarboxylic acid derivatives
    Patent number: 7700653
    Abstract: This invention relates to methods for treating cardiovascular disorders selected from heart failure, thromboembolic disorders, venous diseases, and fibriotic disorders other than fibrosis of the liver, comprising administering an effective amount of a compound of formula (I) wherein the several variables are as defined in the specification and claims.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: April 20, 2010
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Michael Härter, Michael G. Hahn, Claudia Hirth-Dietrich, Andreas Knorr, Elke Stahl, Johannes-Peter Stasch, Frank Wunder
  • Dicarboxylic acid derivatives with pharmaceutical properties
    Patent number: 7674825
    Abstract: The present invention relates to the use of compounds of the formula (I) and to their salts and stereoisomers, for the preparation of medicaments for the treatment of cardiovascular disorders.
    Type: Grant
    Filed: June 27, 2007
    Date of Patent: March 9, 2010
    Assignee: Bayer Aktiengesellschaft
    Inventors: Cristina Alonso-Alija, Markus Heil, Dietmar Flubacher, Paul Naab, Johannes-Peter Stasch, Frank Wunder, Klaus Dembowsky, Elisabeth Perzborn, Elke Stahl
  • Dicarboxylic Acid Derivatives and their Use
    Publication number: 20100029772
    Abstract: The present application relates to novel dicarboxylic acid derivatives, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prevention of cardiovascular disorders.
    Type: Application
    Filed: October 17, 2006
    Publication date: February 4, 2010
    Inventors: Stephan Bartel, Michael Hahn, Wahed Ahmed Moradi, Eva-Maria Becker, Thomas Rölle, Johannes-Peter Stasch, Karl-Heinz Schlemmer, Frank Wunder, Andreas Knorr, Dieter Lang
  • PYRAZOLOPYRIDINE, INDAZOLE, IMIDAZOPYRIDINE, IMIDAZOPYRIMIDINE, PYRAZOLOPYRAZINE AND PYRAZOLOPYRIDINE DERIVATIVES AS STIMULATORS OF GUANYLATE CYCLASE FOR CARDIOVASCULAR DISORDERS
    Publication number: 20100029653
    Abstract: The present application relates to novel azabicyclic compounds, processes for their preparation, their use alone or in combinations for the treatment and/or prevention of diseases, and their use for producing medicaments for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular disorders.
    Type: Application
    Filed: September 1, 2007
    Publication date: February 4, 2010
    Applicant: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Hartmut Schirok, Joachim Mittendorf, Johannes-Peter Stasch, Frank Wunder, Friederike Stoll, Karl-Heinz Schlemmer
  • novel use of activators and stimulators of soluble guanylate cyclase for the prevention or treatment of renal disorders
    Publication number: 20100016305
    Abstract: The present invention relates generally to a method for the treatment of renal failure or renal hypertension and, more particularly, for improving the recovery from acute renal failure or renal hypertension by treatment with activators of soluble guanylate cyclase or stimulators of guanylate cyclase.
    Type: Application
    Filed: July 6, 2006
    Publication date: January 21, 2010
    Applicant: Bayer Healthcare AG
    Inventors: Thomas Krahn, Johannes-Peter Stasch, Gerrit Weimann, Wolfgang Thielemann, Matthias Rinke
  • Heterocyclic Substituted, Anellated Pyrazole Derivative and its uses
    Publication number: 20100004235
    Abstract: The present application relates to novel heterocyclyl-substituted fused pyrazole derivatives, to processes for their preparation, to their use, alone or in combination, for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders.
    Type: Application
    Filed: April 17, 2007
    Publication date: January 7, 2010
    Applicant: BAYER HEALTHCARE AG
    Inventors: Hartmut Schirok, Nils Griebenow, Chantal Fürstner, Joachim Mittendorf, Johannes-Peter Stasch, Frank Wunder, Karl-Heinz Schlemmer, Stefan Heitmeier, Friederike Stoll
  • Novel, Acyclically Substituted Furopyrimidine Derivatives and Use Thereof
    Publication number: 20090318475
    Abstract: The present application relates to novel, acyclically substituted furopyrimidine derivatives, methods for their production, their use for the treatment and/or prophylaxis of diseases and their use for the production of medicinal products for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular diseases.
    Type: Application
    Filed: December 8, 2006
    Publication date: December 24, 2009
    Applicant: BAYER HEALTHCARE AG
    Inventors: Thomas Lampe, Eva-Maria Becker, Raimund Kast, Hartmut Beck, Mario Jeske, Joachim Schuhmacher, Friederike Stoll, Martina Klein, Metin Akbaba, Andreas Knorr, Johannes-Peter Stasch, Lars Bärfacker, Alexander Hillisch, Gunter Karig, Mark Meininghaus, Karl-Heinz Schlemmer, Rudolf Schohe-Loop
  • Use of Activators of Soluble Guanylate Cyclase for Treating Reperfusion Damage
    Publication number: 20090298822
    Abstract: The present invention relates to the use of compounds for manufacturing a pharmaceutical product/medicament for the prophylaxis and/or treatment of reperfusion damage.
    Type: Application
    Filed: July 6, 2006
    Publication date: December 3, 2009
    Applicant: Bayer Health Care
    Inventors: Thomas Krahn, Johannes-peter Stasch, Gerrit Weimann, Wolfgang Thielemann
  • Difluorophenol Derivatives and Their Use
    Publication number: 20090291993
    Abstract: The present application relates to novel difluorophenol derivatives, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prevention of cardiovascular disorders.
    Type: Application
    Filed: October 9, 2006
    Publication date: November 26, 2009
    Inventors: Stephan Bartel, Michael Hahn, Wahed Ahmed Moradi, Eva-Maria Becker, Thomas Rölle, Johannes-Peter Stasch, Karl-Heinz Schlemmer, Frank Wunder, Andreas Knorr
  • Cyclopropylacetic Acid Derivatives and Use Thereof
    Publication number: 20090286882
    Abstract: The present application relates to novel cyclopropylacetic acid derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prevention of cardiovascular disorders.
    Type: Application
    Filed: October 9, 2006
    Publication date: November 19, 2009
    Applicant: BAYER HEALTHCARE AG
    Inventors: Eva-Maria Becker, Michael Hahn, Andreas Knorr, Christian Pilger, Johannes-Peter Stasch, Kari-Heinz Schlemmer, Frank Wunder
  • Use of Suluble Guanylate Cyclase Acitvators for Treating Acute and Chronic Lung Diseases
    Publication number: 20090286781
    Abstract: The present invention relates to the use of compounds of the formulae I-VI for manufacturing a pharmaceutical for the treatment of acute and chronic lung disorders such as the respiratory distress syndromes [acute lung injury (ALI), acute respiratory distress syndrome (ARDS)] and the treatment of COPD.
    Type: Application
    Filed: September 23, 2006
    Publication date: November 19, 2009
    Applicant: Bayer HealtHCare AG
    Inventors: Thomas Krahn, Johannes-peter Stasch, Gerrit Weimann, Wolfgang Thielemann
  • Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases
    Publication number: 20090227640
    Abstract: The present application relates to novel heterocyclic compounds, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prevention of cardiovascular disorders.
    Type: Application
    Filed: October 9, 2006
    Publication date: September 10, 2009
    Applicant: BAYER HEALTHCARE AG
    Inventors: Stephan Bartel, Michael Hahn, Wahed Ahmed Moradi, Klaus Münter, Thomas Rölle, Johannes-Peter Stasch, Karl-Heinz Schlemmer, Frank Wunder
  • Use of Activators of Soluble Guanylate Cyclase for Promoting Wound Healing
    Publication number: 20090221573
    Abstract: The present invention relates to a method for promoting wound healing by administering one or more compounds identified in the claims, and to pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: July 6, 2006
    Publication date: September 3, 2009
    Applicant: Bayer HealthCare AG
    Inventors: Thomas Krahn, Johannes-Peter Stasch, Gerrit Weimann, Wolfgang Thielemann, Beatrix Stelte-Ludwig
  • Use of soluble guanylate cyclase activators for the treatment of Raynaud's Phenomenon
    Publication number: 20090215769
    Abstract: The present invention relates to a method for prevention or treatment of primary and secondary Raynaud's phenomenon comprising administration of an effective amount of a compound selected from compounds of formulae I-IV, and to pharmaceutical compositions containing these compounds.
    Type: Application
    Filed: July 4, 2006
    Publication date: August 27, 2009
    Applicant: Bayer HealthCare AG
    Inventors: Thomas Krahn, Johannes-Peter Stasch, Gerrit Weimann, Wolfgang Thielemann
  • Tetrazole Derivatives and Their Use for the Treatment of Cardiovascular Diseases
    Publication number: 20090215843
    Abstract: The present application relates to novel tetrazole derivatives, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prevention of cardiovascular disorders.
    Type: Application
    Filed: October 9, 2006
    Publication date: August 27, 2009
    Inventors: Stephan Bartel, Michael Hahn, Wahed Ahmed Moradi, Eva-Maria Becker, Thomas Rölle, Johannes-Peter Stasch, Karl-Heinz Schlemmer, Frank Wunder, Andreas Knorr
  • NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES
    Publication number: 20090203906
    Abstract: The invention relates to compounds of formulae (II), (IV), and (VI) as shown below, wherein the several variable groups are as defined in the specification and claims. Processes for making these materials, and methods for using them in the synthesis of compounds for treatment of cardiovascular disorders and fibrotic disorders are also disclosed.
    Type: Application
    Filed: April 13, 2009
    Publication date: August 13, 2009
    Applicant: Bayer Aktiengesellschaft
    Inventors: Cristina Alonso-Alija, Markus Heil, Dietmar Flubacher, Paul Naab, Josef Pernerstorfer, Johannes-Peter Stasch, Frank Wunder, Klaus Dembowsky, Elizabeth Perzborn, Elke Stahl
  • Aminodicarboxylic acid derivatives having pharmaceutical properties
    Patent number: 7517896
    Abstract: The invention relates to compounds of formulae (II), (IV), and (VI) as shown below, wherein the several variable groups are as defined in the specification and claims. Processes for making these materials, and methods for using them in the synthesis of compounds for treatment of cardiovascular disorders and fibrotic disorders are also disclosed.
    Type: Grant
    Filed: August 8, 2005
    Date of Patent: April 14, 2009
    Assignee: Bayer Aktiengesellschaft
    Inventors: Cristina Alonso-Alija, Markus Heil, Dietmar Flubacher, Paul Naab, Josef Pernerstorfer, Johannes-Peter Stasch, Frank Wunder, Klaus Dembowsky, Elizabeth Perzborn, Elke Stahl